Brancaccio, G.; Salpini, R.; Piermatteo, L.; Surdo, M.; Fini, V.; Colagrossi, L.; Cantone, M.; Battisti, A.; Oda, Y.; Di Carlo, D.;
et al. An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression. Microorganisms 2021, 9, 752.
https://doi.org/10.3390/microorganisms9040752
AMA Style
Brancaccio G, Salpini R, Piermatteo L, Surdo M, Fini V, Colagrossi L, Cantone M, Battisti A, Oda Y, Di Carlo D,
et al. An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression. Microorganisms. 2021; 9(4):752.
https://doi.org/10.3390/microorganisms9040752
Chicago/Turabian Style
Brancaccio, Giuseppina, Romina Salpini, Lorenzo Piermatteo, Matteo Surdo, Vanessa Fini, Luna Colagrossi, Marco Cantone, Arianna Battisti, Yasunori Oda, Domenico Di Carlo,
and et al. 2021. "An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression" Microorganisms 9, no. 4: 752.
https://doi.org/10.3390/microorganisms9040752
APA Style
Brancaccio, G., Salpini, R., Piermatteo, L., Surdo, M., Fini, V., Colagrossi, L., Cantone, M., Battisti, A., Oda, Y., Di Carlo, D., Ceccherini-Silberstein, F., Perno, C. F., Gaeta, G. B., & Svicher, V.
(2021). An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression. Microorganisms, 9(4), 752.
https://doi.org/10.3390/microorganisms9040752